APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer https://www.biorxiv.org/content/10.1101/2023.07.02.547443v1?med=mas
APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer https://www.biorxiv.org/content/10.1101/2023.07.02.547443v1?med=mas